Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
McKinsey
US Army
Johnson and Johnson
Deloitte
Healthtrust
Teva
Baxter

Generated: May 25, 2018

DrugPatentWatch Database Preview

Theophylline sodium glycinate - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for theophylline sodium glycinate and what is the scope of theophylline sodium glycinate freedom to operate?

Theophylline sodium glycinate
is the generic ingredient in two branded drugs marketed by Cent Pharms and Novartis, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for theophylline sodium glycinate.
Summary for theophylline sodium glycinate
Synonyms for theophylline sodium glycinate
10092-68-9
2S36N8T753
8000-10-0
AM011076
Asbron (TN)
C7H7N4O2.C2H5NO2.Na
C9H10N5NaO4
CHEMBL1200578
CTK3E8046
D06104
Glycine, mixt. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione, monosodium salt
GLYCINE, SODIUM SALT, compd. with THEOPHYLLINE
K416
LS-177523
LS-72876
Pemophyllin
SCHEMBL122089
Sodium theophylline glycinate
Theophylline sodium glycinate (USP)
Theophylline sodium glycinate [USAN]
Theophylline sodium mixture with glycine
UNII-2S36N8T753

US Patents and Regulatory Information for theophylline sodium glycinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cent Pharms SYNOPHYLATE theophylline sodium glycinate ELIXIR;ORAL 006333-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis ASBRON theophylline sodium glycinate TABLET;ORAL 085148-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Cantor Fitzgerald
McKinsey
Covington
Deloitte
Queensland Health
Cipla
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.